cancer

brainBrain Barriers Breached to Attack Tumors

The brain has barriers to protect itself from bacteria and other pathogens but if infections and diseases get past those barriers then the immune system is also kept out. Yale researchers have found a way to get immune system rescuers …

antiagingTHIO is a Telomerase-Mediated Approach to Fighting Cancer

Telomerase is present in 90% of human cancer cells and contributes significantly to proliferative abilities and immortality of cancer cells. MAIA Biotechnology is developing a Telomerase-Mediated Approach to Fighting Cancer. Telomerase is either absent or shows low activity in normal …

cancerHow Close Are We to Curing Cancer?

It’s a question that everybody’s asking, since everyone knows someone who has been diagnosed or is currently dealing with some form of cancer: just how close are we to curing the disease? We’re at a point where a cancer diagnosis …

cancerNew Gene Targeting Cancer Drugs And Other Advances in Cancer Medicine

A new cancer drugs work by targeting tumors by their genetic make-up instead of where originate in the body. On November 26, 2018, the Food and Drug Administration granted accelerated approval to larotrectinib (VITRAKVI, Loxo Oncology Inc. and Bayer) for …

cancerOver 60% of Previously Inoperable Pancreatic Cancers Now Removable

A combination treatment of intensive chemotherapy and radiation therapy, as well as the blood pressure drug losartan enables many previously inoperable pancreatic cancer tumors to be removed. The work was done at Massachusetts General Hospital and will expand to more …

cancerNuclear Fusion Company TAE Technologies First Product is a Better Cancer Radiation Treatment Device

TAE Life Sciences, division of TAE Technologies, will use low energy neutrons to destroy cancer tumors without damaging healthy tissue. They are using nuclear science know-how that they have built up from their continuing pursuit of commercial nuclear fusion to …

cancerProgrammable Hybrid DNA-Protein Nanotechnology

Advancing toward a whole new hybrid field of protein-DNA nanotechnology with capabilities beyond DNA and Protein nanotechnology alone.

age reversalBillionaire Antiaging Investor Jim Mellon Predicts We Will Live to 115-150 Years

Jim Mellon is a billionaire investor in antiaging companies. Jim has made several investments in antiaging companies and as one of the leading investors in the field gets pitched almost all of the antiaging companies. Jim thus has a unique …